“…The majority of studies have been focused on enhancing drug bioavailability and reducing dosing frequencies [ 11 , 12 ]. This can be achieved by several pharmaceutical approaches, including, for example, coating systems [ 13 ], osmotic pressure systems [ 14 ], and matrices systems [ 15 ]. They can be made of polymers [ 16 , 17 ], lipids [ 18 ], chitosan [ 19 ], starch [ 20 ], cellulose [ 21 ], polyester amide [ 22 ], polycarbonates [ 23 ], or hydroxypropyl methylcellulose (HPMC) [ 24 ].…”